Analysis of the role of keratinocyte Stat3 using the epithelia-specific gene ablation technology.
Analysis of the role of keratinocyte Stat3 using the epithelia-specific gene ablation technology.
批准号:
11670828
负责人:
SANO Shigetoshi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have established keratinocyte-specific Stat3-disrupted mice by using Cre-loxP system under the keratin 5 promoter in order to Investigate the role of Stat3 in signaling required within keratinocytes, since germline ablation of Stat3 gene resulted in early embryonic lethality. Although Stat3-disrupted mice were born normal and no alteration in the skin was found, It was found that wound healing was greatly retarded and the second hair cycle was absent. In vitro migration assay revealed that growth factor-mediated cell migration was markedly impaired in Stat3-disrupted keratinocytes, while their proliferative responses were Intact. These results indicated that Stat3 in keratinocytes was dispensable for skin morphogenesis, but essential for the skin remodeling including wound healing and the progression of the second hair cycle, the processes which required keratinocyte migration. Interestingly, anagen of Stat3- disrupted mice was Induced by topical application of PMA or hair plucking compared to control mice. Furthermore, we found that Stat3-disrupted keratinocytes migrated in vitro upon PKC activation. Given that anagen process required keratinocyte migration, these results suggested that there were at least two distinct pathways for anagen progression based on keratinocyte migration, Stat3-dependent and independent pathways. Interestingly, both signal pathways required PI3K activation. Thus we elucidated signaling pathways and their crosstalks that are Involved in hair cycling using keratinocyte-specific Stat3-disrupted mice.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Takeda J.: "Conditional gene targeting and its application in the skin"J. Dermatol. Sci. (in press). (2000)
Takeda J.:“条件基因靶向及其在皮肤中的应用”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kawamoto S,Niwa H,Tashiro F,Sano S,Kondoh G,Takeda J,Tabayashi K,Miyazaki J.: "A novel reporter mouse strain that expresses enhanced green fluorescen protein upon Cre-mediated recombination."FEBS Lett.. 470. 263-268 (2000)
Kawamoto S、Niwa H、Tashiro F、Sano S、Kondoh G、Takeda J、Tabayashi K、Miyazaki J.:“一种新型报告小鼠品系,在 Cre 介导的重组后表达增强的绿色荧光蛋白。”FEBS Lett.. 470。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sano S,Kira M,Takagi S,Yoshikawa K,Takeda J,Itami S.: "Two distinct signaling pathways in hair cycle induction : Stat3-dependent and-independent pathways."Proc Natl Acad Sci USA.. 97. 13824-13829 (2000)
Sano S,Kira M,Takagi S,Yoshikawa K,Takeda J,Itami S.:“毛发周期诱导中的两种不同的信号传导途径:Stat3 依赖和独立途径。”Proc Natl Acad Sci USA.. 97. 13824-13829
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
佐野栄紀: "毛包成長とSTAT3"臨床皮膚科. (印刷中). (2001)
Eiki Sano:“毛囊生长和 STAT3”临床皮肤病学(印刷中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sano S,Itami S,Takeda K,Tarutani M,Yamaguchi Y,Miura H,Yoshikawa K,Akira S,Takeda J.: "Keratinocyte specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis."EMBO J. 18. 4657-4668 (1999)
Sano S、Itami S、Takeda K、Tarutani M、Yamaguchi Y、Miura H、Yoshikawa K、Akira S、Takeda J.:“Stat3 的角质形成细胞特异性消融表现出皮肤重塑受损,但不影响皮肤形态发生。”EMBO J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 8 条
Study on mechanism of dermatitis due to epidermal barrier disruption : analysis of model mouse with epidermis devoid of ceramide
-
批准号:21591436
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:SANO Shigetoshi
-
依托单位:
Analyses of the patho mechanism of Stat3 activation a crosstalk between epidermal and immunocytes require for the development of psonriasis
-
批准号:18390313
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.36万
-
财政年份:2006
-
负责人:SANO Shigetoshi
-
依托单位:
Analysis of the role of Stat3 in protecting apoptosis in skin
-
批准号:13670885
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2001
-
负责人:SANO Shigetoshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
瘤内链球菌促进STAT3的O-GlcNAc修饰驱动鼻咽癌免疫抑制微环境的机制研究
-
批准号:JCZRLH202600778
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
STAT3/C/EBPD-SLC5A12生物轴调控内质网应激相关蛋白乳酸化修饰在脓毒症急性肺损伤中的作用及机制研究
-
批准号:JCZRLH202602096
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
利妥昔单抗经B细胞耗竭调控SOST/STAT3磷酸化抑制成纤维细胞活化治疗系统性硬化症相关间质性肺疾病(SSc-ILD)的作用机制研究
-
批准号:2026JJ80940
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄婧
-
依托单位:
内皮细胞通过PRDX6-AS1/STAT3轴介导周细胞双硫死亡在急性缺血性卒中脑微循环无复流中的作用及机制研究
-
批准号:2026JJ82211
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗求云
-
依托单位:
基于ACO2-JAK/STAT3信号轴探讨芫荽及其活性成分改善动脉粥样硬化的药理机制研究
-
批准号:2026JJ82274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:侯凯
-
依托单位:
莪术醇纳米颗粒通过STAT3/GPX4通路诱导非小细胞肺癌铁死亡的机制研究
-
批准号:JCZRLH202600865
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
FBXO42 经 Ube2m-Rbx1 轴促进 STAT3 介导的巨噬细胞线粒体自噬抗动脉粥样硬化的机制研究
-
批准号:ZCLQN26H0201
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈凌燕
-
依托单位:
ATXN1基因多态性经STAT3/PD-L1轴调控非小细胞肺癌免疫治疗耐药的机制及靶向干预研究
-
批准号:2026JJ60562
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:佘磊
-
依托单位:
IL-10通过STAT3磷酸化编码调控椎间盘退变中“保护-病理”双重效应的机制研究
-
批准号:2026JJ82659
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:汤亮
-
依托单位:
基于miR125b-5p介导STAT3信号轴对慢加急性肝衰竭肝细胞自噬的影响探讨茵陈蒿汤干预的作用机制
-
批准号:2026JJ82395
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱文芳
-
依托单位: